Faeth Therapeutics, Inc.
NASDAQFTH short interest surges to 76.8% of float, up 49.5% in one week as cost to borrow falls to 112.7%.
Faeth Therapeutics is at the centre of a striking divergence this week: short sellers are rapidly covering a historically extreme position while the company's own CFO is stepping in to buy shares on the open…
Sensei Biotherapeutics heads into its May 22 earnings call in one of the most extreme short-side configurations available in the market today. The borrow market is comprehensively seized up. Short interest has reached…
Snapshot as of 12 Aug 2026
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for FTH — free to start on ORTEX.
Sign up for free →Open FTH on ORTEX